Overview

HLA Typing Market is projected to value over USD 1 billion by 2027 end with a CAGR of over 6.5% during the forecast period 2020 to 2027.

Increased insistence for diagnostic products, increased private-public collaboration for extensive HLA research, rising prevalence of infectious diseases and soaring number of transplant processes are some of the crucial factors responsible for the growth of the market. HLA class I and II antigen identification is performed by the procedure of molecular diagnostics that is based on DNA. These novel innovations of the DNA are being utilised by the HLA typing that provide more accurate, vigorous results that rely on identifying the differences in HLA genes. Furthermore, advancements in technology, rise in the number of processes that involve stem cell transplantation, soft tissue transplantation and solid organ transplantation, bolstering support in R&D, escalating public and private funds are some of the other driving factors responsible for the HLA typing market growth. Additionally, the technological shift to gene-based HLA profiling from serological assays shall boost the proliferation of the market. 

Market Segmentation:

By Technology
•    Molecular Assay Technologies
•    Non-Molecular Assay Technology
By Products and Services
•    Reagents and Consumables
•    Instruments
•    Software and Services
By Application
•    Diagnostic Applications
•    Research Applications
By End User
•    Independent Reference Laboratories
•    Hospitals and Transplant Centers
•    Research Laboratories
•    Academic Institutes
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is fragmented into technology, products and services, application, end user and region. The technology segment is categorised into molecular assay technology and non-molecular assay technology. The molecular assay technology is divided into PCR-based molecular assays and sequencing based molecular assays. The molecular assay technology segment is predicted to hold the largest HLA typing market and this can be credited to the advantages provided by assays like high procedural efficacy, low turnaround time, real-time sample analysis and multi sample studying. The products and service segment is divided into reagents and consumables, instruments, software and services. The application segment is bifurcated into diagnostic applications and research applications. The end user segment is classified into hospitals and transplant centres, research laboratories, academic institutes and independent reference laboratories. The independent reference laboratories dominated the market, and this can be credited to the automation and rapid modernization of diagnostic labs, increased R&D activities that are outsourced by biotech and pharmaceutical companies.

Regional Analysis:

The North America region is expected to subjugate the market during the forecast period owing to advancements in the healthcare, increase in the number of organ transplantation surgeries performed and advancements in the transplant diagnostic technology.

Competitive Landscape:                            

Some of the major players of the market are Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, CareDx Inc., Immucor Inc., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., Hologic Inc., Luminex, Biofortuna, Takara Bio, Omixon. 
Thermo Fisher Scientific provide different modalities for diagnostic imaging for transplant diagnostic surgeries including HLA typing. The company has emphasized on launching new products, collaborations and agreements for sustaining their leadership position.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global HLA typing market by technology, by product and service, by application, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions     

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1 Objectives of the Study 
        1.2 Market Definition 
        1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
        1.4 Currency
        1.5 Limitations 
        1.6 Stakeholders     
2. Research Methodology 
        2.1 Research Data 
              2.1.1 Secondary Data
                      2.1.1.1 Key Data from Secondary Sources
              2.1.2 Primary Data
                      2.1.2.1 Key Data from Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Market Variables, Trends & Scope
        4.1 Market Lineage Outlook
        4.2 Penetration and Growth Prospect Mapping
        4.3 Industry Value Chain Analysis
        4.4 Cost Analysis Breakdown
        4.5 Technology Overview
        4.6 Regulatory Framework on Country Level
                4.6.1 Reimbursement Framework    
                4.6.2 Standards and Compliances
5. Market Overview
         5.1 Market Dynamics
               5.1.1 Market Driver Analysis         
               5.1.2 Market Restraint Analysis         
               5.1.3 Industry Challenges                   
6. Market Analysis tools                      
         6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry                  
         6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. HLA Typing Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Molecular Assay Technologies
              7.1.1 PCR-Based Molecular Assays
                      7.1.1.1 Real-Time PCR
                      7.1.1.2 Sequence-Specific Primer PCR
                      7.1.1.3 Sequence Specific Oligonucleotide PCR
                      7.1.1.4 Other PCR Molecular Assays
              7.1.2 Sequencing based Molecular Assays
                     7.1.2.1 Sanger Sequencing
                     7.1.2.2 Next Generation Sequencing
                     7.1.2.3 Other Sequencing Based Molecular Assays
         7.2 Non-Molecular Assay Technology                    
8. HLA Typing Market, By Product and Service Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Reagents and Consumables
         8.2 Instruments
         8.3 Software and Services
9. HLA Typing Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Diagnostic Applications
               9.1.1 Antibody Screening
               9.1.2 Chimerism Monitoring 
               9.1.3 Others
         9.2 Research Applications 
10. HLA Typing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         10.1 Independent Reference Laboratories
         10.2 Hospitals and Transplant Centers
         10.3 Research Laboratories
         10.4 Academic Institutes
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                11.2.1. U.S.
                11.2.2. Canada
                11.2.3. Mexico 
                11.2.4. Rest of North America
         11.3 Market Size (USD Mn) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Regional Market Trends
         12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.3.1. Brazil
                12.3.2. Venezuela
                12.3.3. Argentina
                12.3.4. Rest of Latin America
         12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
               13.2.1. Germany
                13.2.2. U.K
                13.2.3. France
                13.2.4. Italy
                13.2.5 Switzerland
                13.2.6. Spain
                13.2.7. Russia
                13.2.8. Poland
                13.2.9. Rest of Western Europe
         13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         14.1 Introduction
         14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 14.2.1 Japan
                 14.2.2 China
                 14.2.3 Singapore
                 14.2.4 Korea         
                 14.2.5 India
                 14.2.6 Australia and New Zealand
                 14.2.7 ASEAN
                 14.2.8 Rest of Asia Pacific
         14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    15.1 Introduction
    15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
        15.2.1 UAE
        15.2.2 South Africa
        15.2.3 Egypt
        15.2.4 Saudi Arabia
        15.2.5 Rest of MEA
    15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    16.1 Thermo Fisher Scientific Inc.
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2 QIAGEN N.V.
              16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.2.2. Product Portfolio
              16.2.3. SWOT Analysis
              16.2.4. Financial Overview
              16.2.5. Strategic Overview
    16.3 Illumina
              16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.3.2. Product Portfolio
              16.3.3. SWOT Analysis
              16.3.4. Financial Overview
              16.3.5. Strategic Overview
    16.4 CareDx Inc.
            16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.4.2. Product Portfolio
             16.4.3. SWOT Analysis
             16.4.4. Financial Overview
             16.4.5. Strategic Overview
    16.5 Immucor Inc.
              16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.5.2. Product Portfolio
              16.5.3. SWOT Analysis
              16.5.4. Financial Overview
              16.5.5. Strategic Overview
    16.6 Bio-Rad Laboratories Inc.
              16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.6.2. Product Portfolio
              16.6.3. SWOT Analysis
              16.6.4. Financial Overview
              16.6.5. Strategic Overview
    16.7 F. Hoffman-La Roche Ltd.
             16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.7.2. Product Portfolio
             16.7.3. SWOT Analysis
             16.7.4. Financial Overview
             16.7.5. Strategic Overview
    16.8 Hologic Inc.
              16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.8.2. Product Portfolio
              16.8.3. SWOT Analysis
              16.8.4. Financial Overview
              16.8.5. Strategic Overview    
    16.9 Luminex
              16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.9.2. Product Portfolio
              16.9.3. SWOT Analysis
              16.9.4. Financial Overview
              16.9.5. Strategic Overview
    16.10 Biofortuna
              16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.10.2. Product Portfolio
              16.10.3. SWOT Analysis
              16.10.4. Financial Overview
              16.10.5. Strategic Overview
    16.11 Takara Bio
              16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.11.2. Product Portfolio
              16.11.3. SWOT Analysis
              16.11.4. Financial Overview
              16.11.5. Strategic Overview
    16.12 Omixon
             16.12.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.12.2. Product Portfolio
             16.12.3. SWOT Analysis
             16.12.4. Financial Overview
             16.12.5. Strategic Overview     
16. Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
17. Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions              
      18.3 Licensing and partnerships
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies                        
19. Relevant Case Studies and Latest News Updates
20. Research Sources and List of Primary Contacts of this Study
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics 

Tables

Figures